Adverse events of recreational cannabis use reported to the French addictovigilance network (2012‐2017)

National database study found a tripling of reported adverse events between 2012 and 2017 (179 to 562). Many AEs were reported, including psychiatric (51.2%), neurological (15.6%) and cardiovascular (7.8%) The most common AE was dependence (ranging from 10% to 20.3%).

British Journal of Clinical Pharmacology